Upon correlation of CD44 protein expression with patient clinicopathologic characteristics, it was seen that CD44-high patients had significantly advanced American Joint Committee on Cancer (AJCC) stage and T stage tumours (Table 4). Here, CD44 is linked to neoplasm.